MD654Y - Metoda de pronosticare a evolutiei melanomului malign de stadiul II si III - Google Patents

Metoda de pronosticare a evolutiei melanomului malign de stadiul II si III Download PDF

Info

Publication number
MD654Y
MD654Y MDS20120167A MD654Y MD 654 Y MD654 Y MD 654Y MD S20120167 A MDS20120167 A MD S20120167A MD 654 Y MD654 Y MD 654Y
Authority
MD
Moldova
Prior art keywords
course
malignant melanoma
predicting
iii stage
tct
Prior art date
Application number
Other languages
English (en)
Moldavian (mo)
Inventor
Valeriu Palade
Constantin Jucovschi
Victor Cernat
Gheorghe Tabarna
Iulian Turcanu
Original Assignee
Valeriu Palade
Constantin Jucovschi
Victor Cernat
Gheorghe Tabarna
Iulian Turcanu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valeriu Palade, Constantin Jucovschi, Victor Cernat, Gheorghe Tabarna, Iulian Turcanu filed Critical Valeriu Palade
Priority to MDS20120167A priority Critical patent/MD654Z/ro
Publication of MD654Y publication Critical patent/MD654Y/ro
Publication of MD654Z publication Critical patent/MD654Z/ro

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Inventia se refera la medicina, în special la oncologie si poate fi utilizata pentru pronosticarea evolutiei melanomului malign de stadiul II si III.Conform inventiei, metoda revendicata include examenul clinic si paraclinic, unde se stabilesc urmatorii parametri: concretizarea stadiului bolii (ST), prezenta ulceratiei (U), tipul celular al tumorii (TCT), nivelul de invazie dupa Clark (NI), grosimea tumorii dupa Breslow (GT); metoda de tratament aplicata (MT) si sexul pacientului (SP), apoi se calculeaza functia discriminanta (F) conform formulei:F= -6,345 + 1,386 × ST + 4,768 × MT - 2,596 × SP - 3, 384 × U + 0,806 × TCT + 1,780 × NI - 1, 136 × GT.În cazul în care F < 0 se prognozeaza o evolutie favorabila a melanomului malign, iar când F > 0 - o evolutie nefavorabila.
MDS20120167A 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III MD654Z (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20120167A MD654Z (ro) 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20120167A MD654Z (ro) 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III

Publications (2)

Publication Number Publication Date
MD654Y true MD654Y (ro) 2013-07-31
MD654Z MD654Z (ro) 2014-02-28

Family

ID=48875337

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20120167A MD654Z (ro) 2012-11-20 2012-11-20 Metodă de pronosticare a evoluţiei melanomului malign de stadiul II şi III

Country Status (1)

Country Link
MD (1) MD654Z (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD726Z (ro) * 2013-07-23 2014-08-31 Адриан КИШКА Metodă de pronostic al evoluţiei stărilor precanceroase gastrice la bărbaţi

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD239Z (ro) * 2010-02-15 2011-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de pronosticare a evoluţiei clinice a cancerului glandei mamare stadiul I
  • 2012

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD726Z (ro) * 2013-07-23 2014-08-31 Адриан КИШКА Metodă de pronostic al evoluţiei stărilor precanceroase gastrice la bărbaţi

Also Published As

Publication number Publication date
MD654Z (ro) 2014-02-28

Similar Documents

Publication Publication Date Title
WO2014205555A8 (en) Methods and uses for diagnosis and treatment of prostate cancer
EA202092276A3 (ru) Антитело, распознающее лейкемический ингибиторный фактор (lif) человека, и применение антител против lif при лечении заболеваний, связанных с нежелательной пролиферацией клеток
WO2010091049A3 (en) Diagnosis and treatment of cancer
EP4219760A3 (en) Methods, compositions, and devices utilizing microrna to determine physiological conditions
EP4303584A3 (en) Methods for detecting signatures of disease or conditions in bodily fluids
WO2009039397A3 (en) Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
MX2013000821A (es) Nuevas aminopirazoloquinazolinas.
WO2009009752A3 (en) Genetic models for stratification of cancer risk
EA200901555A1 (ru) Композиция местного применения по уходу за кожей и способ лечения
MX349550B (es) 1,7-diazacarbazoles y metodos de uso.
MX2011014029A (es) Antagonistas de la trayectoria hedgehog de ftalazina disustituida.
MY157124A (en) Substituted imidazopyridinyl-aminopyridine compounds
UA111756C2 (uk) Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
MY176944A (en) Substituted pyrimidines for the treatment of diseases such as cancer
MY160006A (en) Thiazolopyridine sirtuin modulating compounds
NZ597545A (en) Peptide epoxyketones for proteasome inhibition
MX2016007171A (es) Compuestos de heteroaril piridona y azapiridona con funcionalidad electrofila.
WO2010059241A3 (en) Treatment of amyotrophic lateral sclerosis
WO2011002834A3 (en) Compositions and methods for diagnosis and treatment of type 1 diabetes
EP4327886A3 (en) Pyrimido- pyridazinone compounds and use thereof
MX2010006039A (es) Compuestos antagonistas del acido ribonucleico para la modulacion de la expresion de la fosfoinositida-3-cinasa catalitica.
MX2010003071A (es) Uso de n-fenilamidas de acido 2-sulfonilaminobenzoico sustituidas con sulfonilo en el tratamiento del dolor.
WO2013106766A3 (en) THERAPEUTIC INDICATIONS OF miR-1291
EP4327818A3 (en) Improved anti-senescence compounds and uses for the treatment of cancer

Legal Events

Date Code Title Description
FG9Y Short term patent issued
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)
MM4Y Short-term patent definitely lapsed due to non-payment of fees